Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial
Condition(s) studied
Investigational drug(s) / intervention(s)
Diagnostic Test: Head Up Tilt Table (HUT): Participant randomized to open-label diagnostic strategy. Results and all follow-up care to be in the hands of treating cardiologist as this is a pragmatic study. the early HUT \[protocol: supine pre-tilt phase 5 min, un-medicated HUT to 70 degrees for 20 minutes; if response negative then 400 μg of sublingual nitroglycerin and continued 70 degree tilt for 20 minutes\]
Device: Implantable Loop Recorder: ILR is a small subcutaneously implanted device, lasting up to 3 years, that records heart rhythms, and which may be either auto-triggered or patientactivated.
Study summary
The Study To Understand Tilt Tests versus Extended Recordings (STUTTER, POST 10) will test the hypothesis that first performing a diagnostic HUT in older patients with syncope of unknown cause will provide earlier and more diagnoses than inserting an ICM.
Eligibility
Primary outcome measure(s)
- The primary outcome will be the determination of the diagnosis of the cause of syncope (PRECIS2 criterion 8, 5/5) within 2 years. — within 2 years
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Calgary | Calgary | Alberta | Recruiting |
More University of Calgary trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05776810 on ClinicalTrials.gov ↗ ← All trials in Canada